Friedenthal Financial Invests $978,000 in HCA Healthcare, Inc. $HCA

Friedenthal Financial purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,067 shares of the company’s stock, valued at approximately $978,000.

A number of other institutional investors have also modified their holdings of HCA. Brighton Jones LLC bought a new position in HCA Healthcare in the fourth quarter worth approximately $1,021,000. NewEdge Advisors LLC lifted its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC increased its stake in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the period. Jump Financial LLC bought a new position in HCA Healthcare during the 2nd quarter worth about $2,073,000. Finally, Sei Investments Co. lifted its position in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of HCA stock opened at $388.38 on Thursday. The stock’s fifty day moving average price is $412.73 and its 200 day moving average price is $466.54. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The company has a market cap of $86.16 billion, a price-to-earnings ratio of 13.36, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA was highlighted as a top value stock for long-term investors, reinforcing the view that the shares may be attractive based on fundamentals and valuation. Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
• Positive Sentiment: TriStar, part of HCA, received a certificate of need to build a freestanding emergency room in Lebanon, which supports continued facility expansion and local growth. TriStar gains certificate of need to build freestanding ER in Lebanon
• Positive Sentiment: HCA Healthcare Foundation awarded $2.1 million in grants to 89 Middle Tennessee nonprofits, reinforcing community ties and brand goodwill in a core market. 89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation
• Neutral Sentiment: HCA sold 31 home health and hospice agencies, and DAI is acquiring 24 home health agencies from HCA, suggesting ongoing portfolio reshaping but not an obviously major earnings catalyst. HCA sells 31 home health, hospice agencies DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home
• Neutral Sentiment: Coverage on the Frist family and HCA’s history, along with the naming of a new hospital CEO and a healthcare CEO pay list, is largely informational and unlikely to move the stock by itself. Frist family letter reveals the values that built HCA Healthcare by Dr. Thomas Frist Sr. HCA HealthONE names CEO of 2 Denver hospitals 23 highest-paid healthcare CEOs: Wall Street Journal
• Negative Sentiment: HCA’s chief clinical officer is set to exit after four years, creating some leadership turnover at the company. HCA’s chief clinical officer to exit after 4 years

Analyst Ratings Changes

A number of brokerages recently commented on HCA. Argus reduced their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Barclays cut their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Stephens dropped their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Jefferies Financial Group reiterated a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a report on Friday, April 24th. Finally, Mizuho raised their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.